Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$65,203,359
+$36,694,931 QoQ
Shares Held
4,815,610
+1.2% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. OGN ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,203,359 | 4,815,610 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $28,508,428 | 4,759,337 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,985,419 | 4,600,477 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $51,430,415 | 4,815,582 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $42,551,382 | 4,395,804 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $67,262,685 | 4,517,306 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $63,562,451 | 4,260,218 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $81,266,305 | 4,248,108 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $86,233,880 | 4,165,888 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $74,286,395 | 3,951,404 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $56,298,059 | 3,904,165 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $99,372,702 | 5,724,234 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $116,268,882 | 5,587,164 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $128,044,220 | 5,444,057 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $163,436,835 | 5,851,659 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $136,036,953 | 5,813,545 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $174,413,520 | 5,167,808 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $193,310,374 | 5,534,222 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $164,043,498 | 5,387,307 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $156,497,193 | 4,772,711 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $153,421,861 | 5,070,121 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||